Syon Capital’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.44M Buy
33,008
+10,736
+48% +$497K 0.05% 372
2026
Q2
$951K Sell
22,272
-1,883
-8% -$102K 0.04% 373
2026
Q1
$1.52M Sell
24,155
-3,746
-13% -$300K 0.08% 195
2025
Q4
$2.66M Buy
27,901
+691
+3% +$67.7K 0.13% 116
2025
Q3
$2.66M Buy
27,210
+1,745
+7% +$181K 0.14% 101
2025
Q2
$2.74M Buy
25,465
+4,277
+20% +$433K 0.18% 81
2025
Q1
$2.14M Buy
21,188
+2,239
+12% +$225K 0.17% 88
2024
Q4
$1.69M Sell
18,949
-1,009
-5% -$88.8K 0.15% 98
2024
Q3
$1.67M Buy
19,958
+20
+0.1% +$1.58K 0.15% 104
2024
Q2
$1.54M Buy
19,938
+307
+2% +$22.5K 0.14% 109
2024
Q1
$1.34M Buy
19,631
+562
+3% +$36.1K 0.13% 120
2023
Q4
$1.1M Buy
19,069
+819
+4% +$43.7K 0.11% 129
2023
Q3
$964K Buy
+18,250
New +$957K 0.12% 110

Other funds holding BSX

Syon Capital's BSX Position: Q3 2026 in Review

Syon Capital increased its Boston Scientific (BSX) stake by 48% in Q3 2026, buying an estimated $497K and bringing the position to 33,008 shares worth $1.44M. The position accounts for 0.05% of the portfolio, ranked #372.

Syon Capital first reported a position in BSX in Q3 2023 and has held it in 13 quarters since. The position peaked at $2.74M in Q2 2025. 1,497 funds tracked by Wall St. Rank hold BSX as of Q3 2026.

  • Syon Capital held 33,008 shares of Boston Scientific worth $1.44M as of Q3 2026.
  • Syon Capital bought 10,736 Boston Scientific shares in Q3 2026, an estimated $497K.
  • Boston Scientific made up 0.05% of Syon Capital's portfolio in Q3 2026, its #372 holding.
  • Syon Capital first reported a position in Boston Scientific in Q3 2023 and has held it in 13 quarters since.
  • Syon Capital's Boston Scientific position peaked at $2.74M in Q2 2025.
  • 1,497 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2026.

Based on Syon Capital's 13F filing for Q3 2026, filed 16 Nov 2026.